Ex vivo immunostaining for Ki-67 revealed significantly less proliferation of cancer cells within the patient-derived SCLC xenografts of mice treated with cabergoline than of control mice treated with vehicle (Fig. 2g-h). The gene discussed is MKI67; the disease is small cell lung carcinoma.